AC Immune S.A. (ACIU) NASDAQ
2.76
-0.03(-1.08%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.76
-0.03(-1.08%)
Currency In USD
| Market Cap | 250.92M |
| Enterprise Value | 228.64M |
| P/E Ratio | -3.18 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 62.91 |
| Price/Book Ratio | 4.97 |
| Enterprise/Revenue | 56.68 |
| Enterprise/EBITDA | -2.97 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -19.69 |
| Operating Margin | -19.27 |
| Return On Assets | -0.46 |
| Return On Equity | -1.02 |
| Revenue | 3.57M |
| Revenue/Share | 0.04 |
| Gross Profit | 3.57M |
| EBITDA | -63.47M |
| Net Income | -67.28M |
| Diluted EPS | -0.67 |
| Total Cash | 91.52M |
| Total Cash/Share | 0.9 |
| Total Debt | 4.55M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 1.02 |
| Book Value Per Share | 0.44 |
| 52-Week Change | 55.93 |
| 52-Week High | 4 |
| 52-Week Low | 1.43 |
| Moving Average 50 Days | 2.99 |
| Moving Average 200 Days | 2.8 |
| Average Volume | 322,156 |
| Shares Outstanding | 101.77M |
| % Held by Institutions | 26.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |